Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 22451062)

1.

A hyphenated microLC-Q-TOF-MS platform for exosomal lipidomics investigations: application to RCC urinary exosomes.

Del Boccio P, Raimondo F, Pieragostino D, Morosi L, Cozzi G, Sacchetta P, Magni F, Pitto M, Urbani A.

Electrophoresis. 2012 Feb;33(4):689-96. doi: 10.1002/elps.201100375.

PMID:
22451062
2.

A comprehensive urinary metabolomic approach for identifying kidney cancerr.

Kind T, Tolstikov V, Fiehn O, Weiss RH.

Anal Biochem. 2007 Apr 15;363(2):185-95. Epub 2007 Jan 26.

PMID:
17316536
3.

Proteomic evaluation of urine from renal cell carcinoma using SELDI-TOF-MS and tree analysis pattern.

Wu DL, Zhang WH, Wang WJ, Jing SB, Xu YM.

Technol Cancer Res Treat. 2008 Jun;7(3):155-60.

PMID:
18473487
4.

Urine screening by Seldi-Tof, followed by biomarker identification, in a Brazilian cohort of patients with renal cell carcinoma (RCC).

Alves G, Pereira DA, Sandim V, Ornellas AA, Escher N, Melle C, von Eggeling F.

Int Braz J Urol. 2013 Mar-Apr;39(2):228-39. doi: 10.1590/S1677-5538.IBJU.2013.02.12.

5.

Differential protein profiling of renal cell carcinoma urinary exosomes.

Raimondo F, Morosi L, Corbetta S, Chinello C, Brambilla P, Della Mina P, Villa A, Albo G, Battaglia C, Bosari S, Magni F, Pitto M.

Mol Biosyst. 2013 Jun;9(6):1220-33. doi: 10.1039/c3mb25582d. Epub 2013 Mar 19.

PMID:
23511837
6.

[Screening urine markers of renal cell carcinoma using SELDI-TOF-MS].

Wu DL, Wang WJ, Guan M, Jin SB, Jin CR, Zhang YF.

Zhonghua Yi Xue Za Zhi. 2004 Jul 2;84(13):1092-5. Chinese.

PMID:
15312509
7.

Proteomics analysis of bladder cancer exosomes.

Welton JL, Khanna S, Giles PJ, Brennan P, Brewis IA, Staffurth J, Mason MD, Clayton A.

Mol Cell Proteomics. 2010 Jun;9(6):1324-38. doi: 10.1074/mcp.M000063-MCP201. Epub 2010 Mar 11.

8.

Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.

Xu G, Xiang CQ, Lu Y, Kang XN, Liao P, Ding Q, Zhang YF.

Cancer Lett. 2009 Sep 18;282(2):205-13. doi: 10.1016/j.canlet.2009.03.017. Epub 2009 Apr 11.

PMID:
19362769
9.

Validation of SELDI-TOF MS serum protein profiles for renal cell carcinoma in new populations.

Engwegen JY, Mehra N, Haanen JB, Bonfrer JM, Schellens JH, Voest EE, Beijnen JH.

Lab Invest. 2007 Feb;87(2):161-72.

10.

Urinary exosomes and diabetic nephropathy: a proteomic approach.

Raimondo F, Corbetta S, Morosi L, Chinello C, Gianazza E, Castoldi G, Di Gioia C, Bombardi C, Stella A, Battaglia C, Bianchi C, Magni F, Pitto M.

Mol Biosyst. 2013 Jun;9(6):1139-46. doi: 10.1039/c2mb25396h.

PMID:
23344851
12.

Urinary total arsenic and 8-hydroxydeoxyguanosine are associated with renal cell carcinoma in an area without obvious arsenic exposure.

Huang CY, Su CT, Chung CJ, Pu YS, Chu JS, Yang HY, Wu CC, Hsueh YM.

Toxicol Appl Pharmacol. 2012 Aug 1;262(3):349-54. doi: 10.1016/j.taap.2012.05.013. Epub 2012 May 30.

PMID:
22659136
13.

Identification of 2 serum biomarkers of renal cell carcinoma by surface enhanced laser desorption/ionization mass spectrometry.

Hara T, Honda K, Ono M, Naito K, Hirohashi S, Yamada T.

J Urol. 2005 Oct;174(4 Pt 1):1213-7.

PMID:
16145372
14.

Identification of alphaB-crystallin, a biomarker of renal cell carcinoma by SELDI-TOF MS.

Holcakova J, Hernychova L, Bouchal P, Brozkova K, Zaloudik J, Valik D, Nenutil R, Vojtesek B.

Int J Biol Markers. 2008 Jan-Mar;23(1):48-53.

PMID:
18409151
16.

SELDI-TOF-MS-based serum proteomic screening in combination with CT scan distinguishes renal cell carcinoma from benign renal tumors and healthy persons.

Xu G, Xiang CQ, Lu Y, Wang WJ, Kang XN, Liao P, Ding Q, Zhang YF.

Technol Cancer Res Treat. 2009 Jun;8(3):225-30.

PMID:
19445540
17.
18.

Proteomic identification of exosomal LRG1: a potential urinary biomarker for detecting NSCLC.

Li Y, Zhang Y, Qiu F, Qiu Z.

Electrophoresis. 2011 Aug;32(15):1976-83. doi: 10.1002/elps.201000598. Epub 2011 May 9.

PMID:
21557262
19.

[Proteomic analysis in combination with CT diagnosis to distinguish renal cell carcinoma from renal benign masses].

Xu G, Xiang CQ, Lu Y, Kang XN, Wang WJ, Liao P, Ding Q, Zhang YF.

Zhonghua Yi Xue Za Zhi. 2008 Mar 25;88(12):858-60. Chinese.

PMID:
18756995
20.

Urinary nuclear matrix protein 22 for diagnosis of renal cell carcinoma.

Kaya K, Ayan S, Gokce G, Kilicarslan H, Yildiz E, Gultekin EY.

Scand J Urol Nephrol. 2005;39(1):25-9.

PMID:
15764267
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk